Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur, University of California Irvine, United States

Assoc Prof Dr. Gagan Mathur: Candidate for Best Researcher Award Evaluation

Publication profile

Employment History

Dr. Gagan Mathur is a highly experienced professional with a strong background in transfusion medicine and clinical pathology. Since December 2022, he has served as the Medical Director of Transfusion Medicine-Blood Bank at the University of California Irvine School of Medicine, where he also holds the role of Associate Program Director of the Pathology Residency Program. He has previously held prominent positions at the Children’s Hospital Los Angeles and Saint Luke’s Health System in Kansas City, demonstrating his leadership and expertise in managing complex medical and educational settings.

Post-Graduate Training and Education

Dr. Mathur’s rigorous academic background includes a fellowship in Transfusion Medicine/Blood Banking and a residency in Clinical Pathology at the University of Iowa Hospitals & Clinics. He also holds an MBA from the University of Iowa, which complements his medical expertise with business acumen. His foundational medical education was completed at Dr. S.N. Medical College in India.

Certifications and Licensure

Dr. Mathur is board-certified in both Transfusion Medicine/Blood Banking and Clinical Pathology by the American Board of Pathology. He holds medical licenses in California and previously held licenses in Missouri, Kansas, and Iowa. His certification as a Certified Physician Executive underscores his commitment to leadership in healthcare.

Awards and Distinctions

Dr. Mathur has been recognized for his contributions to medicine with numerous accolades, including being named a Top Pathologist by Best in California Magazine in 2023 and a multiple nominee for the Orange County Physician of Excellence award. His early recognition includes the Paul E. Strandjord Young Investigator Award and an Outstanding Reviewer award from a leading scientific journal.

Teaching and Mentoring

Dr. Mathur is actively involved in teaching and mentoring the next generation of medical professionals. He serves as an Associate Program Director and Chair of the Clinical Competency Committee in the Pathology Residency Program at UC Irvine. He also contributes as a faculty member in various transfusion medicine and blood banking courses for medical students, residents, fellows, and clinical laboratory scientist students.

Publication Top Notes

  • Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22 (Journal of Analytical Toxicology) – Cited by 206, 2014 🧪📊
  • Antibody testing for COVID-19: can it be used as a screening tool in areas with low prevalence? (American Journal of Clinical Pathology) – Cited by 90, 2020 🦠🔬
  • High clinical suspicion of donor‐derived disease leads to timely recognition and early intervention to treat solid organ transplant‐transmitted lymphocytic choriomeningitis virus (Transplant Infectious Disease) – Cited by 29, 2017 🏥🦠
  • Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research (Journal of Pathology Informatics) – Cited by 25, 2015 📈🧑‍💻
  • Clinical profile and mortality among novel influenza A (H1N1) infected patients: 2009-2010 Jodhpur, Rajasthan pandemic (Journal of the Association of Physicians of India) – Cited by 25, 2013 🏥🌍
  • Antibody testing for COVID-19 (American Journal of Clinical Pathology) – Cited by 7, 2020 🦠🧬
  • Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection (Transfusion) – Cited by 7, 2017 🩸🔬
  • A clinico-epidemiologic study of neurologic associations and factors related to speech and language delay (National Journal of Community Medicine) – Cited by 7, 2012 🧠🗣️
  • Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4 kilogram neonate (Transfusion and Apheresis Science) – Cited by 5, 2018 🍼🩸
  • Streamlined sign-out of capillary protein electrophoresis using middleware and an open-source macro application (Journal of Pathology Informatics) – Cited by 5, 2014 🧬💻
  • A case for a national registry of red blood cell antibodies (Vox Sanguinis) – Cited by 4, 2022 🩸🧾
  • Predicting changes in hemoglobin S after simple transfusion using complete blood counts (Transfusion) – Cited by 3, 2018 🩸🧪
  • A case cluster of lymphocytic choriomeningitis virus transmitted via organ transplantation (Transplantation) – Cited by 2, 2014 🦠🏥


Conclusion

Assoc Prof Dr. Gagan Mathur’s extensive experience, academic background, and leadership roles make him a strong candidate for the Best Researcher Award. His contributions to transfusion medicine, combined with his teaching and mentoring roles, demonstrate a commitment to advancing medical science and education. His recognition by peers and multiple accolades further support his suitability for this prestigious award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

 

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus

Zhenhan Deng | Medicine and Dentistry | Best Researcher Award

Zhenhan Deng | Medicine and Dentistry | Best Researcher Award

Dr Zhenhan Deng, The First Affiliated Hospital of Wenzhou Medical University, China

Dr. Zhenhan Deng is a distinguished orthopedic surgeon born on July 19, 1989. He currently serves as a Deputy Chief Physician at The First Affiliated Hospital of Wenzhou Medical University in China 🇨🇳. Dr. Deng completed his Ph.D. at Xiangya Hospital, CSU, and was a visiting scholar at the University of Texas Health Science Center 🏥. His research focuses on osteoarthritis and cartilage regeneration, supported by significant grants and notable publications 📚. He has received multiple awards, including the Orthopaedic Research Society’s New Investigator Recognition Award and the Shenzhen Health Elite Talent title 🌟. For more details, visit his official website 🌐.

Publication profile

google scholar

Education

Deng pursued his Ph.D. in Orthopedics at Xiangya Hospital, Central South University (CSU), Hunan, China, from September 2015 to November 2018. Additionally, he was a Visiting Scholar at the University of Texas Health Science Center at Houston, focusing on Orthopedics, from December 2016 to September 2018. Prior to his doctoral studies, Deng completed his Master of Medicine and Bachelor of Medicine degrees at Xiangya Hospital, CSU.

Work Experience

Throughout his career, Deng has held various positions in orthopedic surgery and sports medicine. He served as a Deputy Chief Physician in the Department of Orthopedic Surgery at The First Affiliated Hospital of Wenzhou Medical University from December 2023 to September 2023. Prior to this, he worked as an Attending Physician in the same department. Deng also gained experience as an Attending Physician in the Department of Sports Medicine at Shenzhen Second People’s Hospital, Shenzhen, Guangdong, China, from September 2020 to September 2023, after starting as a Resident Physician in December 2018.

Awards

Deng has received numerous awards and honors for his contributions to orthopedic research and clinical practice. Notable accolades include being nominated for the Orthopaedic Research Society (ORS) New Investigator Recognition Awards (NIRA), winning the Orthopaedic Research Society (ORS) ON Foundation/ORS Orthoregeneration Award, and receiving recognition as an Outstanding Graduate of Hunan Province.

Research focus

Zhenhan Deng is an orthopaedic surgeon and researcher focused on advancing treatments for musculoskeletal conditions, particularly osteoarthritis and cartilage repair. His research encompasses the development of innovative therapies, such as microgel scaffolds, mesenchymal stem cells, and gene therapy to promote cartilage regeneration and joint repair. Deng’s work includes investigating the roles of various signaling pathways in disease progression and treatment efficacy. His projects and publications underscore his commitment to improving patient outcomes through cutting-edge, translational medical research. 🩺🦴🧬🔬💡🌟

For further information, you can visit his personal work website at https://dzhdr.haodf.com/.

Publication top notes

  1. Electrical stimulation for pain relief in knee osteoarthritis: systematic review and network meta-analysis
    C Zeng, T Yang, Z Deng, Y Yang, Y Zhang, G Lei
    Osteoarthritis and Cartilage, 2015 – 179 citations 📊
  2. Effectiveness of continuous and pulsed ultrasound for the management of knee osteoarthritis: a systematic review and network meta-analysis
    C Zeng, H Li, T Yang, ZH Deng, Y Yang, Y Zhang, X Ding, GH Lei
    Osteoarthritis and Cartilage, 2014 – 158 citations 📉
  3. Macrophages in osteoarthritis: pathophysiology and therapeutics
    Y Chen, W Jiang, H Yong, M He, Y Yang, Z Deng, Y Li
    American Journal of Translational Research, 2020 – 118 citations 🦠
  4. Bone morphogenetic proteins for articular cartilage regeneration
    ZH Deng, YS Li, X Gao, GH Lei, J Huard
    Osteoarthritis and Cartilage, 2018 – 103 citations 💉
  5. The role of sirtuin 1 and its activator, resveratrol in osteoarthritis
    Z Deng, Y Li, H Liu, S Xiao, L Li, J Tian, C Cheng, G Zhang, F Zhang
    Bioscience Reports, 2019 – 97 citations 🍇
  6. Long noncoding RNAs in osteoarthritis
    J Lu, Z Deng, Y Li, G Lei
    Joint Bone Spine, 2017 – 88 citations 🧬
  7. Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments
    S Liu, Z Deng, K Chen, S Jian, F Zhou, Y Yang, Z Fu, H Xie, J Xiong, …
    Molecular Medicine Reports, 2022 – 86 citations 🦴
  8. Is posterior tibial slope associated with noncontact anterior cruciate ligament injury?
    C Zeng, T Yang, S Wu, S Gao, H Li, Z Deng, Y Zhang, G Lei
    Knee Surgery, Sports Traumatology, Arthroscopy, 2016 – 81 citations 🏃‍♂️
  9. Characterization of a novel polyvinyl alcohol/chitosan porous hydrogel combined with bone marrow mesenchymal stem cells and its application in articular cartilage repair
    L Peng, Y Zhou, W Lu, W Zhu, Y Li, K Chen, G Zhang, J Xu, Z Deng, …
    BMC Musculoskeletal Disorders, 2019 – 73 citations 💧
  10. Association between dietary magnesium intake and radiographic knee osteoarthritis
    C Zeng, H Li, J Wei, T Yang, Z Deng, Y Yang, Y Zhang, T Yang, G Lei
    PLoS One, 2015 – 70 citations 🍽️
  11. RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets
    Z Deng, Y Jia, H Liu, M He, Y Yang, W Xiao, Y Li
    American Journal of Translational Research, 2019 – 67 citations 🔬
  12. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A
    W Luo, H He, W Xiao, Q Liu, Z Deng, Y Lu, Q Wang, Q Zheng, Y Li
    Oncotarget, 2016 – 65 citations 🎯
  13. Alterations of amino acid metabolism in osteoarthritis: its implications for nutrition and health
    Y Li, W Xiao, W Luo, C Zeng, Z Deng, W Ren, G Wu, G Lei
    Amino Acids, 2016 – 63 citations 🍽️
  14. Modified arthroscopic Latarjet procedure: suture-button fixation achieves excellent remodeling at 3-year follow-up
    J Xu, H Liu, W Lu, Z Deng, W Zhu, L Peng, K Ouyang, H Li, D Wang
    The American Journal of Sports Medicine, 2020 – 58 citations 🏅
  15. MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells
    Y Li, W Jiang, Y Hu, Z Da, C Zeng, M Tu, Z Deng, W Xiao
    Oncology Letters, 2016 – 53 citations 🚫
  16. MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2
    X Xie, YS Li, WF Xiao, ZH Deng, HB He, Q Liu, W Luo
    Bioscience Reports, 2017 – 51 citations 🛡️
  17. MicroRNA-127-5p regulates osteopontin expression and osteopontin-mediated proliferation of human chondrocytes
    M Tu, Y Li, C Zeng, Z Deng, S Gao, W Xiao, W Luo, W Jiang, L Li, G Lei
    Scientific Reports, 2016 – 50 citations 🧫
  18. p38MAPK signaling pathway in osteoarthritis: pathological and therapeutic aspects
    Z Li, A Dai, M Yang, S Chen, Z Deng, L Li
    Journal of Inflammation Research, 2022 – 45 citations 🌡️
  19. Diet-intestinal microbiota axis in osteoarthritis: a possible role
    Y Li, W Luo, Z Deng, G Lei
    Mediators of Inflammation, 2016 – 45 citations 🔗
  20. Relationship between cigarette smoking and radiographic knee osteoarthritis in Chinese population: a cross-sectional study
    Y Zhang, C Zeng, H Li, T Yang, Z Deng, Y Yang, X Ding, D Xie, Y Wang, …
    Rheumatology International, 2015 – 45 citations 🚬

Each line provides the title of the paper, the authors, the journal it was published in, the year of publication, the number of citations, and an emoji representing the general theme or content of the paper.